Leuthner M, Reisbeck M, Helou M, Hayden O
Micromachines (Basel). 2024; 15(4).
PMID: 38675331
PMC: 11051966.
DOI: 10.3390/mi15040520.
Chen H, Deng J, Li L, Liu Z, Sun S, Xiong P
Mar Drugs. 2023; 21(11).
PMID: 37999396
PMC: 10672124.
DOI: 10.3390/md21110572.
Lazarski C, Hanley P
Cytotherapy. 2023; 26(2):103-112.
PMID: 37943204
PMC: 10872958.
DOI: 10.1016/j.jcyt.2023.10.005.
Rees P, Summers H, Filby A, Carpenter A, Doan M
Nat Rev Methods Primers. 2023; 2.
PMID: 37655209
PMC: 10468826.
DOI: 10.1038/s43586-022-00167-x.
Fox J, Hashimoto T, Navarro H, Garcia A, Shou B, Goldstein A
Aging (Albany NY). 2023; 15(9):3356-3380.
PMID: 37179121
PMC: 10449296.
DOI: 10.18632/aging.204708.
Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation.
Piede N, Bremm M, Farken A, Pfeffermann L, Cappel C, Bonig H
Cells. 2023; 12(6).
PMID: 36980191
PMC: 10047294.
DOI: 10.3390/cells12060850.
Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells.
Vallejo J, Saigusa R, Gulati R, Suthahar S, Suryawanshi V, Alimadadi A
BMC Biol. 2022; 20(1):193.
PMID: 36045343
PMC: 9434837.
DOI: 10.1186/s12915-022-01382-4.
How I Use Measurable Residual Disease in the Clinical Management of Adult Acute Lymphoblastic Leukemia.
Fernando F, Robertson H, El-Zahab S, Pavlu J
Clin Hematol Int. 2021; 3(4):130-141.
PMID: 34938985
PMC: 8690704.
DOI: 10.2991/chi.k.211119.001.
Bioengineered System for High Throughput Screening of Kv1 Ion Channel Blockers.
Sharonov G, Nekrasova O, Kudryashova K, Kirpichnikov M, Feofanov A
Bioengineering (Basel). 2021; 8(11).
PMID: 34821753
PMC: 8614864.
DOI: 10.3390/bioengineering8110187.
MIMIC: an optimization method to identify cell type-specific marker panel for cell sorting.
Zou M, Duren Z, Yuan Q, Li H, Hutchins A, Wong W
Brief Bioinform. 2021; 22(6).
PMID: 34180954
PMC: 8575015.
DOI: 10.1093/bib/bbab235.
Hyperspectral multiphoton microscopy for visualization of multiple, spectrally overlapped fluorescent labels.
Bares A, Mejooli M, Pender M, Leddon S, Tilley 2nd S, Lin K
Optica. 2021; 7(11):1587-1601.
PMID: 33928182
PMC: 8081374.
DOI: 10.1364/optica.389982.
Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances.
Della Starza I, Chiaretti S, De Propris M, Elia L, Cavalli M, De Novi L
Front Oncol. 2019; 9:726.
PMID: 31448230
PMC: 6692455.
DOI: 10.3389/fonc.2019.00726.
Automated flow cytometric identification of disease-specific cells by the ECLIPSE algorithm.
Folcarelli R, van Staveren S, Bouman R, Hilvering B, Tinnevelt G, Postma G
Sci Rep. 2018; 8(1):10907.
PMID: 30026601
PMC: 6053450.
DOI: 10.1038/s41598-018-29367-w.
Significant common environmental effects on leukocyte subpopulations.
Botzman M, Gat-Viks I
PLoS One. 2018; 13(4):e0196193.
PMID: 29689083
PMC: 5915319.
DOI: 10.1371/journal.pone.0196193.
Lab-on-a-chip electrical multiplexing techniques for cellular and molecular biomarker detection.
Liu F, Ni L, Zhe J
Biomicrofluidics. 2018; 12(2):021501.
PMID: 29682143
PMC: 5893332.
DOI: 10.1063/1.5022168.
A theorem proving approach for automatically synthesizing visualizations of flow cytometry data.
Raj S, Hussain F, Husein Z, Torosdagli N, Turgut D, Deo N
BMC Bioinformatics. 2017; 18(Suppl 8):245.
PMID: 28617220
PMC: 5471952.
DOI: 10.1186/s12859-017-1662-4.
Flow Cytometric Characterization of Antigen-Specific T Cells Based on RNA and Its Advantages in Detecting Infections and Immunological Disorders.
Radford F, Tyagi S, Gennaro M, Pine R, Bushkin Y
Crit Rev Immunol. 2017; 36(5):359-378.
PMID: 28605344
PMC: 5548664.
DOI: 10.1615/CritRevImmunol.2017018316.
Microscopy: A larger palette for biological imaging.
Camp Jr C, Cicerone M
Nature. 2017; 544(7651):423-424.
PMID: 28447648
DOI: 10.1038/544423a.
T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts.
Feucht J, Kayser S, Gorodezki D, Hamieh M, Doring M, Blaeschke F
Oncotarget. 2016; 7(47):76902-76919.
PMID: 27708227
PMC: 5363558.
DOI: 10.18632/oncotarget.12357.
Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model.
Zhen A, Rezek V, Youn C, Rick J, Lam B, Chang N
J Vis Exp. 2016; (113).
PMID: 27404517
PMC: 4993349.
DOI: 10.3791/54048.
